Representative image. Actual product may vary.
This site is optimized for Chrome, Edge, Firefox, and Safari. You may not have the best user experience in your current browser.
Product review summary
MADgic® Laryngo-Tracheal Mucosal Atomization Device - with 3 mL Syringe
The MADgic® Laryngo-Tracheal Mucosal Atomization Device offers a versatile choice to administer medication* across the entire upper airway and beyond the vocal cords.
.
Key features include:
• Consistent, fine atomized spray for direct coverage of nose, pharynx, larynx and trachea
• Long, narrow stylet is designed to be gently curved and flexible, allowing it to reach a patient's vocal cords for targeted coverage
• Adapts to any luer-lock syringe
• Available in adult and pediatric sizes
.
Rapid absorption1
• Atomizes drugs into a fine mist
• Delivers particles at optimal size for rapid mucosal absorption1
.
Reduced cough
•In procedures where a cough upon emergence can cause adverse events, application of topical lidocaine on the laryngotracheal region has been shown to provide a smooth emergence from general anesthesia with reduced coughing2
.
Patient comfort
Adequate topical anesthesia has been shown to:
• Enhance patient comfort3
• Facilitate patient compliance3
.
*For use with drugs approved for intranasal and oropharyngeal delivery.
.
References:
1. Suresh M. Management of Predicted Difficult Airway in A Parturient Undergoing Cesarean Delivery, where Airway Management is Necessary. Shnider and Levinson's Anesthesia for Obstetrics. 2013;(24):381-382.
2. Diachun CA, Tunink BP, Brock-Utne JG. Suppression of cough during emergence from general anesthesia: laryngotracheal lidocaine through a modified endotracheal tube. Journal of Clinical Anesthesia. 2001 13(6):447-451.
3. Leung Y, Vacanti FX. Awake without complaints: maximizing comfort during awake fiberoptic intubation. Journal of Clinical Anesthesia. 2015;27(6):517-519
.
MC-007640